The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
July 9th 2025
Obesity and high-fat diets enhance the aggressiveness of triple-negative breast cancer through exosome-mediated mechanisms, revealing new therapeutic targets.
National Study Examines US Mammography Screening Rates During COVID-19 Pandemic
April 5th 2021The study, conducted by investigators from the Breast Cancer Surveillance Coalition (BCSC), had an objective to quantify the impact of the COVID-19 pandemic on both breast cancer screening and diagnostic mammography services in the United States.
Read More
Stewardship Program Helps Hospitals Reduce Antibiotic Use, Prevent Bacterial Infections
April 5th 2021The overuse of antibiotics in hospitals can lead to the emergence of drug-resistant strains of bacteria or outbreaks of infections by bacteria, such as Clostridiodes difficile (C. difficile).
Read More
COVID-19 Has Devastating Effects for Patients Suffering From COPD
While the prevalence of COVID-19 in patients with COPD is relatively low, those who are infected with the virus experience more severe symptoms than those without COPD.
Read More
Change Management Is a Consideration Beyond the Pandemic
Thoughtful application can reduce resistance and improve overall operations, if consistent steps are followed.
Read More
Study: Drug Coupons, Vouchers Cover Minimum of Prescription Drugs
April 1st 2021The researchers analyzed millions of pharmacy transactions by more than 600,000 people in the United States from 2017 to 2019 in order to get a better sense of how vouchers and other point-of-sale co-payment offsets are used.
Read More
How Pharmacists Can Support Health Care Access and Engagement for Black Same-gender-loving Men
April 1st 2021Russell Brewer, DrPH, a research associate professor at University of Chicago Medicine, discusses the value of the pharmacist in improving access and engagement in care for Black same-gender-loving men.
Watch
APhA Releases New Guide on Trans Inclusion for Pharmacies on Trans Day of Visibility
March 31st 2021March 31 is International Transgender Day of Visibility, and the Human Rights Campaign (HRC) Foundation and the American Pharmacists Association (APhA) partnered to release a new guide for pharmacies on transgender and gender-diverse inclusion.
Read More
Study: Face Masks Strongly Associated With Reducing Health Care Workers' Risk of Acquiring COVID-19
March 31st 2021The team discovered a correlation between the implementation of Henry Ford’s universal mask policy and a significant drop in the rate at which its health care workers tested positive for SARS-CoV-2.
Read More
Study: Vitamin D Supplementation Could Protect From Severe COVID-19
March 31st 2021Earlier research has found that vitamin D supplementation can prevent inflammation in other respiratory diseases, but there have been limited studies examining the role of vitamin D supplementation in COVID-19.
Read More
Pfizer-BioNTech COVID-19 Vaccine Shows Positive Topline Results in Adolescents
March 31st 2021The results from a phase 3 trial in a population of American adolescents aged 12 to 15 years found that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 showed 100% efficacy and robust antibody responses.
Read More
Expert: Health Care Disparities Show ‘Commonalities Between HIV and COVID-19’ in BIPOC Communities
March 30th 2021Russell Brewer, DrPH, a research associate professor at University of Chicago Medicine, discusses the lessons from both the HIV epidemic and the COVID-19 pandemic in regard to how health systems can more effectively address health care disparities in BIPOC communities.
Watch
Russell Brewer, DrPH, a research associate professor at University of Chicago Medicine, and P.J. Moton-Poole, a senior manager at ViiV Healthcare, discuss the expansion of the accelerate initiative, which funds projects that support the health and wellbeing of Black same-gender-loving men throughout the United States.
Watch
FDA Approves First Anti-BCMA CAR T-Cell Therapy for Relapsed, Refractory Multiple Myeloma
March 29th 2021In a clinical trial of idecabtagene vicleucel in multiple myeloma, the overall response rate for the efficacy evaluable population was 72%, and 28% of participants achieved a stringent complete response.
Read More